UGT1A1 and metabolic dysfunction-associated steatohepatitis: Therefore, potential molecular mechanisms leading to the deregulation of FXR and PPARα activation possibly arising as a consequence of altered UGT1A activity in htgUGT1A-SNP mice are discussed and compared to the results of human population studies observed during NAFLD and NASH.